Literature DB >> 8880728

Behavioral consequences of intracerebral vasopressin and oxytocin: focus on learning and memory.

M Engelmann1, C T Wotjak, I Neumann, M Ludwig, R Landgraf.   

Abstract

Since the pioneering work of David de Wied and his colleagues, the neuropeptides arginine vasopressin and oxytocin have been thought to play a pivotal role in behavioral regulation in general, and in learning and memory in particular. The present review focuses on the behavioral effects of intracerebral arginine vasopressin and oxytocin, with particular emphasis on the role of these neuropeptides as signals in interneuronal communication. We also discuss several methodological approaches that have been used to reveal the importance of these intracerebral neuropeptides as signals within signaling cascades. The literature suggests that arginine vasopressin improves, and oxytocin impairs, learning and memory. However, a critical analysis of the subject indicates the necessity for a revision of this generalized concept. We suggest that, depending on the behavioral test and the brain area under study, these endogenous neuropeptides are differentially involved in behavioral regulation; thus, generalizations derived from a single behavioral task should be avoided. In particular, recent studies on rodents indicate that socially relevant behaviors triggered by olfactory stimuli and paradigms in which the animals have to cope with an intense stressor (e.g., foot-shock motivated active or passive avoidance) are controlled by both arginine vasopressin and oxytocin released intracerebrally.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880728     DOI: 10.1016/0149-7634(95)00059-3

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  54 in total

Review 1.  Hemoglobin-derived peptides as novel type of bioactive signaling molecules.

Authors:  Ivone Gomes; Camila S Dale; Kimbie Casten; Miriam A Geigner; Fabio C Gozzo; Emer S Ferro; Andrea S Heimann; Lakshmi A Devi
Journal:  AAPS J       Date:  2010-09-02       Impact factor: 4.009

2.  Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart.

Authors:  J Gutkowska; M Jankowski; C Lambert; S Mukaddam-Daher; H H Zingg; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 3.  Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?

Authors:  Guy Griebel; Florian Holsboer
Journal:  Nat Rev Drug Discov       Date:  2012-05-18       Impact factor: 84.694

4.  Evidence for a role of oxytocin receptors in the long-term establishment of dominance hierarchies.

Authors:  Marjan Timmer; M Isabel Cordero; Yannick Sevelinges; Carmen Sandi
Journal:  Neuropsychopharmacology       Date:  2011-07-13       Impact factor: 7.853

5.  Neural correlates of pair-bonding in a monogamous primate.

Authors:  Karen L Bales; William A Mason; Ciprian Catana; Simon R Cherry; Sally P Mendoza
Journal:  Brain Res       Date:  2007-10-11       Impact factor: 3.252

Review 6.  The neurobiology of social attachment: A comparative approach to behavioral, neuroanatomical, and neurochemical studies.

Authors:  Kimberly A Young; Yan Liu; Zuoxin Wang
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2008-03-02       Impact factor: 3.228

7.  Intranasal application of vasopressin fails to elicit changes in brain immediate early gene expression, neural activity and behavioural performance of rats.

Authors:  M Ludwig; V A Tobin; M F Callahan; E Papadaki; A Becker; M Engelmann; G Leng
Journal:  J Neuroendocrinol       Date:  2013-07       Impact factor: 3.627

8.  Nanoparticle formulations that allow for sustained delivery and brain targeting of the neuropeptide oxytocin.

Authors:  Rokon Uz Zaman; Nihal S Mulla; Keegan Braz Gomes; Cherilyn D'Souza; Kevin Sean Murnane; Martin J D'Souza
Journal:  Int J Pharm       Date:  2018-07-19       Impact factor: 5.875

Review 9.  Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review.

Authors:  Bart Stragier; Dimitri De Bundel; Sophie Sarre; Ilse Smolders; Georges Vauquelin; Alain Dupont; Yvette Michotte; Patrick Vanderheyden
Journal:  Heart Fail Rev       Date:  2007-11-08       Impact factor: 4.214

Review 10.  Trends in the development of new antidepressants. Is there a light at the end of the tunnel?

Authors:  Pal Pacher; Valeria Kecskemeti
Journal:  Curr Med Chem       Date:  2004-04       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.